Gao et al. demonstrated that the CD63+ CAF subtype contributes to tamoxifen resistance by releasing exosomal miR-22, which leads to the downregulation of ERα and PTEN expression in breast cancer[21]. This evidence concerns the gene ESR1 and breast cancer.